应用光敏反应诊治癌瘤是近年来兴起的一种新技术。目前国外有30～40个医学中心正在进行此项研究,美国、日本、澳大利亚、加拿大、意大利等国开展了许多基础研究并初步应用于临床。我国自1980年北京地区开始研究此项疗法,军内许多单位也十分重视这项技术,继北京市药物工业研究所从牛血中提取血卟啉制成静脉用的血卟啉衍生物后军内兄弟单位在药物提炼、基础研究以及临床实验等方面都有一定进展,现将我院近两 The application of photosensitivity to the diagnosis and treatment of cancer is a new technique that has emerged in recent years. At present, there are 30 to 40 medical centers in foreign countries that are conducting this research. The United States, Japan, Australia, Canada, Italy and other countries have carried out many basic research and are initially applied in clinical practice. China began to study this therapy in the Beijing area in 1980. Many units in the military also attached great importance to this technology. Following the extraction of hematoporphyrins from bovine blood by the Beijing Institute of Pharmaceutical Industry, the use of hematoporphyrin derivatives for intravenous use was investigated. The inner brother unit has made some progress in drug extraction, basic research and clinical experiments.